-
Loading metrics
Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer
- Wen-Hsing Lin,
- Teng-Kuang Yeh,
- Weir-Torn Jiaang,
- Kuei-Jung Yen,
- Chun-Hwa Chen,
- Chin-Ting Huang,
- Shih-Chieh Yen,
- Shu-Yi Hsieh,
- Ling-Hui Chou,
- Ching-Ping Chen
x
- Published: January 8, 2014
- https://doi.org/10.1371/journal.pone.0083160